Vivus

Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
FDA panel to review Qnexa in February 2012
Drug Store News
Fri, 12/23/11 - 08:59 am
FDA
advisory panels
obesity
Qnexa
Vivus
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
6 Biotech Stocks With Consistently Rising Liquidity
Seeking Alpha
Fri, 12/23/11 - 08:49 am
Enzon
Immunogen
Micromet
Oncothyreon
Vivus
QLT
Vivus falls 15% on drug safety study
Marketwatch
Thu, 12/22/11 - 02:44 pm
Vivus
Qnexa
Vivus: analysis links ingredient of weight loss drug Qnexa to greater risk of birth defects
Yahoo/AP
Wed, 12/21/11 - 09:09 pm
Qnexa
birth defects
Vivus
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Market Crash = Biotech Carnage
Motley Fool
Thu, 11/10/11 - 01:05 pm
biotech
Zalicus
Complete Genomics
Pacific Biosciences
Illumina
Arena
Vivus
Vivus Posts Narrower Loss
Yahoo/Zacks.com
Tue, 11/8/11 - 10:33 am
earnings
Vivus
Vivus says FDA accepts weight-loss drug application
Reuters
Fri, 11/4/11 - 09:25 am
FDA
obesity
Vivus
Qnexa
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Bloomberg
Mon, 10/17/11 - 09:30 am
warnings
Vivus
Qnexa
FDA
obesity
Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Mon, 10/3/11 - 11:15 am
Qnexa
obesity
Vivus
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Arena Pharmaceuticals
Orexigen
Vivus
Qnexa
weight loss
obesity
A Shrinking Obesity Market
Motley Fool
Sat, 09/17/11 - 02:51 pm
weight loss
Vivus
Qnexa
Orexigen
Arena Pharmaceuticals
Vivus plans to resubmit potential diet pill Qnexa to FDA next month
Yahoo/AP
Thu, 09/15/11 - 11:52 am
obesity
Vivus
FDA
Qnexa
Vivus says FDA accepts application on ED drug
Yahoo/AP
Fri, 09/2/11 - 02:13 pm
FDA
Vivus
erectile dysfunction
Avanafil
Vivus to raise $45.8M in direct offering
Bizjournals.com
Tue, 08/23/11 - 07:27 pm
Vivus
stock offering
Lower Spend Narrows Loss at Vivus
Yahoo/Zacks.com
Tue, 08/9/11 - 10:11 am
Vivus
earnings
VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction
Yahoo
Thu, 06/30/11 - 08:18 am
Vivus
Avanafil
erectile dysfunction
Vivus' ED Drug on Track
Yahoo/Zacks.com
Wed, 06/22/11 - 10:29 am
Vivus
Avanafil
erectile dysfunction
GSK
Pfizer
Viagra
Levitra

Pages